(Q36731426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

François Lamoureux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Valérie Trichet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Céline Chipoy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

François Gouin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Françoise Redini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

169-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

Stature of young people with malignant bone tumors

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Height as a risk factor for osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

MRI and CT evaluation of primary bone and soft-tissue tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

The treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Surgical options and outcomes in bone sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Radiotherapy for local control of osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Samarium for osteoblastic bone metastases and osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

A systematic review of the role of pulmonary irradiation in the management of primary bone tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Potential of interferon-alpha in solid tumours: part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Mechanisms of Osteoblastic Metastases: Role of Endothelin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Molecular Mechanisms of Bone Metastasis and Therapeutic Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Role of endothelin-1 in osteoblastic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Bisphosphonates: new therapeutic agents for the treatment of bone tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.2.169

21 January 2018

Identifiers

DOI

10.1586/14737140.7.2.169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17288528%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference